Clinical trial
Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance
NCT07020637 is registered in ClinicalTrials.gov with University of Nevada, Las Vegas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance
- Lead sponsor
- University of Nevada, Las Vegas
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 19, 2024
- Completion date
- April 30, 2026
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.